Võrdle meetodeid
Vaata valitud meetodeid kõrvuti; erinevad read on esile tõstetud.
| CHA₂DS₂-VASc skoor× | qSOFA skoor× | |
|---|---|---|
| Valdkond | Kliiniline hindamine | Kliiniline hindamine |
| Perekond | Process / pipeline | Process / pipeline |
| Tekkeaasta≠ | 2010 | 2016 |
| Looja≠ | Gregory Y. H. Lip, Robby Nieuwlaat, et al. | Sepsis-3 Taskforce |
| Tüüp≠ | Atrial fibrillation stroke risk stratification | Rapid sepsis screening |
| Algallikas≠ | Lip, G. Y., Nieuwlaat, R., Pisters, R., Lane, D. A., & Crijns, H. J. (2010). Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest, 137(2), 263-272. DOI ↗ | Singer, M., Deutschman, C. S., Seymour, C. W., et al. (2016). The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA, 315(8), 801-810. DOI ↗ |
| Rööpnimetused | CHA2DS2VASc, Atrial fibrillation stroke risk | Quick SOFA, qSOFA |
| Seotud | 3 | 3 |
| Kokkuvõte≠ | The CHA₂DS₂-VASc score, developed by Lip, Nieuwlaat, and colleagues in 2010, is a 9-point risk stratification tool for predicting annual stroke and systemic thromboembolism risk in patients with atrial fibrillation. It is the recommended score by major cardiology guidelines for guiding anticoagulation decisions. | The Quick Sequential Organ Failure Assessment (qSOFA) score, introduced by the Sepsis-3 taskforce in 2016, is a rapid 3-variable bedside screening tool for identifying non-ICU patients at high risk of sepsis-related mortality. It uses altered mentation, systolic hypotension, and tachypnea to quickly stratify patients without requiring laboratory testing. |
| ScholarGateAndmestik ↗ |
|
|